Results for this period
Third quarter1 January 2026–30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
The Gourmet category offset the decline in throat lozenges, while the Kanro The Strong series and gummies developed in collaboration with retailers performed well. However, the profit margin declined due to higher fixed costs from additional staffing in anticipation of the new gummy line coming online, increased raw material and fuel costs resulting from the situation in the Middle East, and higher selling, general and administrative expenses, including storage and delivery costs, corporate advertising expenses, personnel expenses and depreciation of the new core system.
No applicable items
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 September 2026 |
| Net Sales | ¥25,542 million |
| Operating profit | ¥2,658 million |
| Ordinary income | ¥2,679 million |
| Profit attributable to owners of the parent | ¥1,904 million |
| Net income per share | ¥45.41 |
| Equity ratio | End of the current fiscal period 54.9 % / End of previous period 56.5 % |
| Total assets | ¥33,206 million |
| Net assets | ¥18,217 million |
| Full-year earnings forecast | Net Sales ¥36,500 million (YoY +5.0%) / Operating profit ¥4,200 million (YoY -10.5%) / Ordinary income ¥4,200 million (YoY -11.5%) / Profit attributable to owners of the parent ¥3,000 million (YoY -11.2%) |
| Annual Dividend Forecast | ¥32 per share → ¥33 per share（+3.1%） |
| Segment revenue | Segment Confectionery and Food Products Business / Net Sales ¥25,542 million / Year on year against the same period last year Not disclosed |
| Depreciation and amortization | ¥1,195,218 thousand |
| Impairment loss | ¥97.192 million (assets subject to impairment: Not disclosed) |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥148,513 thousand / Extraordinary loss Loss on sale of property, plant and equipment ¥0 thousand, Loss on disposal of non-current assets ¥3,363 thousand, Impairment loss ¥97,192 thousand |
| Disclosure regarding the going concern assumption | No applicable items |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name None |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 42,946,812 |
| Treasury Shares at Period-End | 1,864,503 |
| Factors Behind Changes in Business Performance | The Gourmet category offset the decline in throat lozenges, while the Kanro The Strong series and gummies developed in collaboration with retailers performed well. However, the profit margin declined due to higher fixed costs from additional staffing in anticipation of the new gummy line coming online, increased raw material and fuel costs resulting from the situation in the Middle East, and higher selling, general and administrative expenses, including storage and delivery costs, corporate advertising expenses, personnel expenses and depreciation of the new core system. |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In terms of revenue, the Gourmet category offset the decline in throat lozenges, while the Kanro The Strong series and gummies developed in collaboration with retailers performed well. In terms of profit, fixed costs increased due to additional staffing in anticipation of the new gummy line coming online, while raw material and fuel costs rose as a result of the situation in the Middle East. Storage and delivery costs, advertising expenses, personnel expenses and depreciation of the new core system also increased.